Comment discusses the measurement of depression risk from finasteride, highlighting comparisons between control groups.
To the Editor,We would like to discuss the recent publication ‘Depression risk of 5-alpha reductase inhibitors: impact of active-comparator versus non-drug user control groups on risk measurement’ ...
No takes yet. Share an insight, caveat, or question.
Mayer Brezis (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: